Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry’s biggest blockbusters.
On Wednesday, the Boston-area biotech …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of direct-to-consumer health services is spawning a new crop of health tech
Autistic youth who were born in underserved neighborhoods are more likely to have greater attention deficit hyperactivity disorder (ADHD) symptoms than those born in communities
Eli Lilly previously inked a $1.4bn deal to acquire radiopharmaceutical company POINT Biopharma in October 2023. Credit: Michael Vi via Shutterstock. Eli Lilly is once